Medicinal Oxygen Air Liquide Sante

Country: Unjoni Ewropea

Lingwa: Ingliż

Sors: EMA (European Medicines Agency)

Ixtrih issa

Ingredjent attiv:

oxygen

Disponibbli minn:

Air Liquide Santé International

Kodiċi ATC:

QV03AN01

INN (Isem Internazzjonali):

oxygen

Grupp terapewtiku:

Horses; Dogs; Cats

Żona terapewtika:

All other therapeutic products

Indikazzjonijiet terapewtiċi:

For oxygen supplementation and as a carrier gas during inhalation anaesthesia.For oxygen supplementation during recovery.

L-istatus ta 'awtorizzazzjoni:

Withdrawn

Data ta 'l-awtorizzazzjoni:

2006-12-20

Fuljett ta 'informazzjoni

                                Medicinal product no longer authorised
B. PACKAGE LEAFLET
12/15
Medicinal product no longer authorised
PACKAGE LEAFLET
Medicinal Oxygen Air Liquide Santé 100 % inhalation gas for dogs,
cats and horses.
1.
NAME AND ADDRESS OF THE MARKETING AUTHORISATION HOLDER AND OF
THE MANUFACTURING AUTHORISATION HOLDER RESPONSIBLE FOR BATCH
RELEASE, IF DIFFERENT
Marketing authorisation holder
:
AIR LIQUIDE Santé INTERNATIONAL
10, rue Cognacq-Jay
75341 Paris Cedex 07
FRANCE
Manufacturer for the batch release
:
AIR LIQUIDE Santé FRANCE
ZI Est, BP 34
54181 Heillecourt Cedex
FRANCE
2.
NAME OF THE VETERINARY MEDICINAL PRODUCT
Medicinal Oxygen Air Liquide Santé 100 % inhalation gas for dogs,
cats and horses.
3.
STATEMENT OF THE ACTIVE SUBSTANCE(S) AND OTHER INGREDIENT(S)
Medicinal Oxygen Air Liquide Santé is an inhalation gas consisting of
100 % oxygen.
4.
INDICATION(S)
Medicinal Oxygen Air Liquide Santé can be used for oxygen
supplementation and as a carrier gas
during inhalation anaesthesia.
The veterinary medicinal product can also be used for oxygen
supplementation during recovery.
5.
CONTRAINDICATIONS
None.
6.
ADVERSE REACTIONS
None.
7.
TARGET SPECIES
Dogs, cats and horses.
13/15
Medicinal product no longer authorised
8.
DOSAGE FOR EACH SPECIES, ROUTE(S) AND METHOD OF ADMINISTRATION
The precise fresh gas flow rate required by an animal during
anaesthesia and recovery should be
determined by a suitably experienced veterinarian, taking into
consideration the bodyweight and health
status of the animal and the anaesthetic equipment and agents being
used. The animal must be
monitored closely, preferably by means of a pulse oximeter, and the
flow rate adapted during
anaesthesia to meet their individual requirements.
9.
ADVICE ON CORRECT ADMINISTRATION
In-circuit oxygen meters can be used to measure the inspired oxygen
fraction and depending on the
individual animal, a level of 50 – 100 % of the veterinary medicinal
product may be required. As a
rule, and if oxygen tension cannot be measured, the inspired oxygen
fraction should
                                
                                Aqra d-dokument sħiħ
                                
                            

Karatteristiċi tal-prodott

                                Medicinal product no longer authorised
ANNEX I
SUMMARY OF PRODUCT CHARACTERISTICS
1/15
Medicinal product no longer authorised
1.
NAME OF THE VETERINARY MEDICINAL PRODUCT
Medicinal Oxygen Air Liquide Santé 100 % inhalation gas for dogs,
cats and horses.
2.
QUALITATIVE AND QUANTITATIVE COMPOSITION
ACTIVE SUBSTANCE:
100 % oxygen.
3.
PHARMACEUTICAL FORM
Inhalation gas.
4.
CLINICAL PARTICULARS
4.1
TARGET SPECIES
Dogs, cats and horses.
4.2
INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES
For oxygen supplementation and as a carrier gas during inhalation
anaesthesia.
For oxygen supplementation during recovery.
4.3
CONTRAINDICATIONS
None.
4.4
SPECIAL WARNINGS 
None.
4.5
SPECIAL PRECAUTIONS FOR USE
SPECIAL PRECAUTIONS FOR USE IN ANIMALS
Oxygen in concentration up to 100 % (FiO
2
1.0) should not exceed 12 hours. Oxygen in concentration
over 80 % (FiO
2
0.8) should not exceed 18 hours.
Animals with pre-existing oxygen radical damage to the lung may have
this damage exacerbated by
oxygen therapy e.g. in the treatment of paraquat poisoning.
SPECIAL PRECAUTIONS TO BE TAKEN BY THE PERSON ADMINISTERING THE
VETERINARY MEDICINAL PRODUCT TO
ANIMALS
This veterinary medicinal product should only be used by persons who
have been fully trained to use
pressure regulators and associated equipment.
Whilst oxygen is non-flammable, it strongly supports combustion and no
naked flames should be
allowed near the container. Since even the smallest spark can cause
violent ignition, electrical
equipment capable of sparking should not be used in the vicinity of
patients receiving oxygen.
2/15
Medicinal product no longer authorised
Cylinder valves and associated equipment must not be lubricated and
must be kept entirely free from
carbon-based oils and grease because otherwise there is a risk of
spontaneous combustion and a
violent explosion may occur.
If you have been working in an oxygen-enriched atmosphere avoid
smoking, open flames or other
sources of ignition for at least 15 minutes
.
4.6
ADVERSE REACTIONS (FREQUENCY 
                                
                                Aqra d-dokument sħiħ
                                
                            

Dokumenti f'lingwi oħra

Fuljett ta 'informazzjoni Fuljett ta 'informazzjoni Bulgaru 12-01-2007
Karatteristiċi tal-prodott Karatteristiċi tal-prodott Bulgaru 12-01-2007
Fuljett ta 'informazzjoni Fuljett ta 'informazzjoni Spanjol 12-01-2007
Karatteristiċi tal-prodott Karatteristiċi tal-prodott Spanjol 12-01-2007
Fuljett ta 'informazzjoni Fuljett ta 'informazzjoni Ċek 12-01-2007
Karatteristiċi tal-prodott Karatteristiċi tal-prodott Ċek 12-01-2007
Fuljett ta 'informazzjoni Fuljett ta 'informazzjoni Daniż 12-01-2007
Karatteristiċi tal-prodott Karatteristiċi tal-prodott Daniż 12-01-2007
Fuljett ta 'informazzjoni Fuljett ta 'informazzjoni Ġermaniż 12-01-2007
Karatteristiċi tal-prodott Karatteristiċi tal-prodott Ġermaniż 12-01-2007
Rapport ta 'Valutazzjoni Pubblika Rapport ta 'Valutazzjoni Pubblika Ġermaniż 12-01-2007
Fuljett ta 'informazzjoni Fuljett ta 'informazzjoni Estonjan 12-01-2007
Karatteristiċi tal-prodott Karatteristiċi tal-prodott Estonjan 12-01-2007
Rapport ta 'Valutazzjoni Pubblika Rapport ta 'Valutazzjoni Pubblika Estonjan 12-01-2007
Fuljett ta 'informazzjoni Fuljett ta 'informazzjoni Grieg 12-01-2007
Karatteristiċi tal-prodott Karatteristiċi tal-prodott Grieg 12-01-2007
Fuljett ta 'informazzjoni Fuljett ta 'informazzjoni Franċiż 12-01-2007
Karatteristiċi tal-prodott Karatteristiċi tal-prodott Franċiż 12-01-2007
Rapport ta 'Valutazzjoni Pubblika Rapport ta 'Valutazzjoni Pubblika Franċiż 12-01-2007
Fuljett ta 'informazzjoni Fuljett ta 'informazzjoni Taljan 12-01-2007
Karatteristiċi tal-prodott Karatteristiċi tal-prodott Taljan 12-01-2007
Fuljett ta 'informazzjoni Fuljett ta 'informazzjoni Latvjan 12-01-2007
Karatteristiċi tal-prodott Karatteristiċi tal-prodott Latvjan 12-01-2007
Fuljett ta 'informazzjoni Fuljett ta 'informazzjoni Litwanjan 12-01-2007
Karatteristiċi tal-prodott Karatteristiċi tal-prodott Litwanjan 12-01-2007
Rapport ta 'Valutazzjoni Pubblika Rapport ta 'Valutazzjoni Pubblika Litwanjan 12-01-2007
Fuljett ta 'informazzjoni Fuljett ta 'informazzjoni Ungeriż 12-01-2007
Karatteristiċi tal-prodott Karatteristiċi tal-prodott Ungeriż 12-01-2007
Rapport ta 'Valutazzjoni Pubblika Rapport ta 'Valutazzjoni Pubblika Ungeriż 12-01-2007
Fuljett ta 'informazzjoni Fuljett ta 'informazzjoni Malti 12-01-2007
Karatteristiċi tal-prodott Karatteristiċi tal-prodott Malti 12-01-2007
Fuljett ta 'informazzjoni Fuljett ta 'informazzjoni Olandiż 12-01-2007
Karatteristiċi tal-prodott Karatteristiċi tal-prodott Olandiż 12-01-2007
Rapport ta 'Valutazzjoni Pubblika Rapport ta 'Valutazzjoni Pubblika Olandiż 12-01-2007
Fuljett ta 'informazzjoni Fuljett ta 'informazzjoni Pollakk 12-01-2007
Karatteristiċi tal-prodott Karatteristiċi tal-prodott Pollakk 12-01-2007
Fuljett ta 'informazzjoni Fuljett ta 'informazzjoni Portugiż 12-01-2007
Karatteristiċi tal-prodott Karatteristiċi tal-prodott Portugiż 12-01-2007
Rapport ta 'Valutazzjoni Pubblika Rapport ta 'Valutazzjoni Pubblika Portugiż 12-01-2007
Fuljett ta 'informazzjoni Fuljett ta 'informazzjoni Rumen 12-01-2007
Karatteristiċi tal-prodott Karatteristiċi tal-prodott Rumen 12-01-2007
Fuljett ta 'informazzjoni Fuljett ta 'informazzjoni Slovakk 12-01-2007
Karatteristiċi tal-prodott Karatteristiċi tal-prodott Slovakk 12-01-2007
Fuljett ta 'informazzjoni Fuljett ta 'informazzjoni Sloven 12-01-2007
Karatteristiċi tal-prodott Karatteristiċi tal-prodott Sloven 12-01-2007
Fuljett ta 'informazzjoni Fuljett ta 'informazzjoni Finlandiż 12-01-2007
Karatteristiċi tal-prodott Karatteristiċi tal-prodott Finlandiż 12-01-2007
Rapport ta 'Valutazzjoni Pubblika Rapport ta 'Valutazzjoni Pubblika Finlandiż 12-01-2007
Fuljett ta 'informazzjoni Fuljett ta 'informazzjoni Svediż 12-01-2007
Karatteristiċi tal-prodott Karatteristiċi tal-prodott Svediż 12-01-2007

Fittex twissijiet relatati ma 'dan il-prodott